Chris Shibutani is an accomplished executive, investor, analyst, and physician with a background spanning finance and healthcare. He holds an MD from Columbia University College of Physicians and Surgeons and an MBA from Columbia Business School, alongside a BA from Harvard College.
Shibutani is slated to become EVP, Chief Strategy Officer at Bristol Myers Squibb in 2025-26.